Attentional Capture by Real-life Episodic Information
EPICAPTURE
1 other identifier
interventional
86
1 country
1
Brief Summary
Attention facilitates the allocation of processing resources and the control of behavior among competing stimuli. Current research focuses primarily on attention control networks in the dorsal frontoparietal (DAN) and ventral (VAN) cortex. However, typical laboratory experiments emphasize task-specific processing, neglecting the possible role of memory. Although a few studies have examined the contribution of memory to attention control, they have generally used simple tasks in the laboratory. These tasks are unlikely to produce true traces of episodic memory, which are - by definition - characterized by complex contextual information (what, where, when) and personal relevance. This research will therefore use an innovative protocol based on mobile phone technology to generate episodes in the participants' real lives and then measure the impact of these past personal experiences on attention allocation (by assessing eye movements) and on the activity of the DAN/VAN system (using functional imaging). The main hypothesis of the study is that knowledge acquired during everyday life contributes to the subsequent allocation of processing resources, via engagement of the DAN/VAN attention systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy-volunteers
Started Dec 2025
Longer than P75 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 18, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2029
April 18, 2025
April 1, 2025
3.1 years
April 11, 2025
April 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
activation pattern in fMRI: "old vs. new" objects (intervention 1)
activation pattern in DAN/VAN system in fMRI experiments for the comparison of trials with gaze directed towards "seen/old vs. unseen/new" objects.
One time during the week after the 3 weeks encoding phase
Secondary Outcomes (2)
activation pattern in fMRI: "place" images in intervention 1
One time during the week after the 3 weeks encoding phase
activation pattern in fMRI: incongruent vs. congruent contexts (intervention 2)
One time during the week after the 3 weeks encoding phase
Study Arms (2)
Old vs new objects
EXPERIMENTALThe following week after the "Old vs new objects" encoding phase of 3 weeks, participants will have an fMRI. During fMRI, participants will see objects already seen or not seen during the encoding phase.
incongruent vs. congruent contexts
EXPERIMENTALThe following week after the "incongruent vs. congruent contexts" encoding phase of 3 weeks, participants will have an fMRI. During fMRI, participants will see objects encoding in congruent or incongruent contexts.
Interventions
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks. The following week, participants will have an fMRI. During fMRI, participants will see objects already seen or not seen during the encoding phase.
During the encoding phase, a set of 60 objects will be presented to the participants in their everyday life. Pictures of objects sent to their app mobile phone over a period of 3 weeks. This time, the objects will be chosen according to the participant's location. The following week, participants will have an fMRI. During fMRI, participants will see objects encoding in congruent/incongruent contexts.
Eligibility Criteria
You may qualify if:
- Be 18 years old to 40 years old
- Be right-handed
- Do not wear glasses
- Have a mobile-phone compatible with the application, minimum 6rd generation Android operating system, with geo-localization activated and accepted by the user
- Undertake to comply with the instructions and recommendations for MRI examination
- Provide informed written consent to participate in the study
You may not qualify if:
- History of known neurological or psychiatric illness
- Cognitive problems limiting the understanding of instructions
- Recent taking psychotropic drugs (antidepressants, anxiolytics, antipsychotics). The main treatments not authorized during this research are the following: Psychotropic treatments (drugs that can induce changes in perception, sensation, mood, consciousness or behavior). Like what:
- Antipsychotics (valproic acid, amisulpride, aripiprazole, clozapine, cyamemazin, haloperidol, loxapine, olanzapine, risperidone).
- Antidepressants (Amitriptyline, Citalopram, Clomipramine, Duloxetine, Escitalopam, Fluoxetine, Mianserine, Mirtazapine, Nortriptyline, Paroxetine, Sertraline, Venlafaxine).
- Anxyolitics
- Pregnant or breastfeeding women
- Persons deprived of their liberty by a judicial or administrative decision
- Persons admitted to a health or social institution for purposes other than research
- Adults subject to a legal protection measure (guardianship, curatorship)
- Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
- Participation in another research study of the current study
- Contraindication for fMRI scanning
- Participant not agreeing to be informed in the event of the incidental discovery of an anomaly on MRI
- For visit number 2 :
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCBL1, CRNL Inserm U1028, CNRS UMR5292, équipe IMPACT
Bron, Rhone, 69500, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 18, 2025
Study Start
December 15, 2025
Primary Completion (Estimated)
January 15, 2029
Study Completion (Estimated)
January 15, 2029
Last Updated
April 18, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share